SARS-CoV-2 (COVID-19) Spike RBD Monoklonale antilichamen [B003]

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS CoV-2 Spike Protein derived from 2019-nCoV is composed of S1 domain and S2 domain. The S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells.

43740568

QHD43416.1

Virus

S-RBD recombinant protein

Unconjugated

Primary Antibodies

Infectious Disease, COVID-19

Greater than 95% as determined by reducing SDS-PAGE.

Batch dependent

PBS with 0.02% sodium azide, 10% glycerol, pH7.2

None

Blue Ice

Store at 4˚ C short term. Aliquot and store at -20˚ C long term. Avoid freeze-thaw cycles.

ELISA: ECD-1:320000, RBD-1:80000 WB: 1:1000~2000

S

Surface glycoprotein

SARS-CoV-2

SARS-CoV-2 (COVID-19, 2019-nCoV) Spike Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Surface Glycoprotein, Spike protein

ELISA, WB, Neutralization Assay

Liquid